The 340B Drug Pricing Program (340B) is a cornerstone of equitable healthcare in the U.S. For more than 30 years, it has ensured that drug manufacturers provide discounted medications to qualifying clinics and Disproportionate Share (DSH) hospitals, enabling them to deliver essential treatment and services to individuals experiencing low income.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Kenneth Schell
Trump and Biden Both Wrong On Health Care
President Donald Trump has finally revealed his most favored nation drug price control plan – and it’s a real humdinger. It is full of government goodies and it pegs drug prices to OECD nations with similar per-capita GDP as the U.S. It may just help him win re-election…at the cost of innovation and patient access to drugs.
Trump and Biden Are Wrong: Top-down Health Care Doesn’t Work | RealClearHealth
By Dr. Kenneth Schell October 05, 2020 President Donald Trump has finally revealed his most favored nation drug price control plan – and it’s a real humdinger. It is full of government goodies and it pegs drug prices to OECD nations with similar per-capita GDP as the U.S. It may just help him win re-election…at the cost of innovation and patient access to drugs.
How Coronavirus Could Threaten America's Prescription Drug Supply
A container is filled with the generic drug "Montelukast Sodium" on Sept. 10, 2018 in Midvale, Utah. Coronavirus-related supply-chain interruptions in China, may cause severe shortages of essential medicines, including antibiotics, heart drugs and painkillers in the U.S.(George Frey/Getty Images) The threat of medicine disruptions from the COVID-19 pandemic may pose a larger threat to public health than the virus itself.
Commentary: U.S. Reliance on China for Generic Drugs Is a Security Threat
China and India now manufacture about 80% of the drugs consumed in the U.S.(Getty Images) Last week, drugmaker Novartis issued a recall of generic versions of the popular heartburn medication Zantac. The Food and Drug Administration recently announced that the drug's active ingredient, ranitidine, had been contaminated with a carcinogen known as NDMA. On Monday, CVS pulled Zantac and its generics from its shelves; Walgreens had already stopped selling the drug earlier.
Commentary: Importing Prescription Drugs Won’t Solve Cost Issues
Efforts to import prescription drugs from Canada received a big boost in May when President Donald Trump reiterated his support for the proposal. Trump reportedly directed Health and Human Services Secretary Alex Azar to work with Florida, which is one of 16 states pursuing importation legislation, to get the necessary federal approvals as quickly as possible. According to Florida Rep.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Kenneth
Contact Kenneth, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack